Everolimus Cumulative Dose and Dose Intensity in Pancreatic Neuroendocrine Tumors

被引：0
作者：
Berardi, R. [1 ]
Torniai, M. [1 ]
Pusceddu, S. [2 ]
Spada, F. [3 ]
Brizzi, M. P. [4 ]
Ibrahim, T. [5 ]
Antonuzzo, L. [6 ]
Ferolla, P. [7 ]
Panzuto, F. [8 ]
Silvestris, N. [9 ]
Partelli, S. [10 ]
Bongiovanni, A. [5 ]
Zichi, C. [4 ]
Riva, N. [5 ]
Rinzivillo, M. [8 ]
机构：
[1] Univ Politecn Marche, Ancona, Italy
[2] INT, Milan, Italy
[3] IEO, Milan, Italy
[4] San Luigi Hosp, Orbassano, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[6] AOU Careggi, Florence, Italy
[7] Osped S Maria Misericordia, Perugia, Italy
[8] Sapienza Univ Rome, St Andrea Hosp, Sch Med, Rome, Italy
[9] Cancer Inst Giovanni Paolo II, Bari, Italy
[10] Univ Vita & Salute, Osped San Raffaele IRCCS, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2016年 / 103卷
关键词：
PNET; Dose intensity; Targeted therapy; Everolimus; Cumulative dose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L2
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
    Berardi, Rossana
    Torniai, Mariangela
    Pusceddu, Sara
    Spada, Francesca
    Ibrahim, Toni
    Brizzi, Maria Pia
    Antonuzzo, Lorenzo
    Ferolla, Piero
    Panzuto, Francesco
    Silvestris, Nicola
    Partelli, Stefano
    Ferretti, Benedetta
    Freddari, Federica
    Gucciardino, Calogero
    Testa, Enrica
    Concas, Laura
    Murgioni, Sabina
    Bongiovanni, Alberto
    Zichi, Clizia
    Riva, Nada
    Rinzivillo, Maria
    Brunetti, Oronzo
    Giustini, Lucio
    Di Costanzo, Francesco
    Delle Fave, Gianfranco
    Fazio, Nicola
    De Braud, Filippo
    Falconi, Massimo
    Cascinu, Stefano
    CANCER MEDICINE, 2017, 6 (07): : 1493 - 1499
  • [2] Clinical Impact of Everolimus Cumulative Dose on Pancreatic Neuroendocrine Tumors (pNETs) Outcome
    Berardi, R.
    Torniai, M.
    Onofri, A.
    Partelli, S.
    Guglielmi, S.
    Gucciardino, C.
    Savini, A.
    Ferretti, B.
    Enrica, T.
    Giustini, L.
    Falconi, M.
    Cascinu, S.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 275 - 275
  • [3] Everolimus for the treatment of pancreatic neuroendocrine tumors
    Feldmann, Georg
    Bisht, Savita
    Schuette, Ute
    Haarmann, Jens
    Brossart, Peter
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (14) : 2073 - 2084
  • [4] The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors
    Taboada, Rodrigo G.
    Brito, Angelo B.
    Silva, Ana Luiza
    Weschenfelder, Rui F.
    Riechelmann, Rachel P.
    CANCERS, 2024, 16 (22)
  • [5] Role of everolimus in pancreatic neuroendocrine tumors
    Goldstein, Robert
    Meyer, Tim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1653 - 1665
  • [6] Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors
    Pavel, Marianne E.
    Chen, David
    He, Wei
    Cushman, Stephanie
    Voi, Maurizio
    de Vries, Elisabeth G. E.
    Baudin, Eric
    Yao, James C.
    PANCREAS, 2017, 46 (06) : 751 - 757
  • [7] Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
    Yao, James C.
    Phan, Alexandria T.
    Jehl, Valentine
    Shah, Gaurav
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2013, 73 (05) : 1449 - 1453
  • [8] Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
    Cen, Putao
    Amato, Robert J.
    ONCOTARGETS AND THERAPY, 2012, 5 : 217 - 224
  • [9] Everolimus: A New Treatment Option for Advanced Pancreatic Neuroendocrine Tumors
    Thompson, Lisa A.
    Kim, Miryoung
    Wenger, Sarah D.
    O'Bryant, Cindy L.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1212 - 1219
  • [10] Inducing, Understanding and Overcoming Resistance to Everolimus in Pancreatic Neuroendocrine Tumors
    Vandamme, T.
    Op de Beeck, K.
    Beyens, M.
    Mortier, G.
    Pauwels, P.
    Van Camp, G.
    De Herder, W.
    Peeters, M.
    Holand, L. J.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 225 - 226
12345